Heart attack damage reversed with injectable RNA therapy, study finds

This Fox News health article reports on a legitimate Columbia University study published in Nature Biomedical Engineering, with appropriate sourcing from the lead researcher (Ke Cheng) and direct quotes from institutional press materials. The reporting demonstrates solid journalistic fundamentals—it explains the mechanism clearly, acknowledges significant limitations (animal-only trials, unknown long-term effects), and avoids overstating the findings with cautious language like 'may repair' and 'designed to.' However, the byline credits Khloe Quill as a 'lifestyle production assistant,' which raises questions about subject-matter expertise; the article would benefit from clarity on whether a medical reporter verified the technical details. The framing is appropriately measured given the early-stage nature of the research, though the optimistic headline paired with the prominent placement of breakthrough language could lead casual readers to overestimate how close this therapy is to clinical use.